Form D · Biotechnology
SPRUCE BIOSCIENCES, INC.
South San Francisco, CA · CIK 0001683553
Offering snapshot reported Oct 17, 2025 · SEC filing
- Reported sold
- $50M Offering amount: $50M
- Investors reported
- 21 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Oct 9, 2025 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Oct 17, 2025 | Initial | $49,999,768 | No comparison | 21 | SEC filing |
| Feb 28, 2023 | Initial | $53,615,720 | No comparison | 20 | SEC filing |
| Aug 14, 2020 | Amendment | $88,000,000 | $44,000,000vs Feb 28, 2020 | 11 | SEC filing |
| Feb 28, 2020 | Initial | $44,000,000 | No comparison | 11 | SEC filing |
Offering details
- Securities
- Equity, Option to acquire, Other
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $3M
- Finders' fees
- $0
- Form D file number
- 021-561207
Equity offering includes common stock and pre-funded warrants to purchase common stock.
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| Leerink Partners LLC | 39011 | |
| Citizens JMP Securities, LLC | 22208 | |
| H.C. Wainwright & Co., LLC | 375 |
Source: Form D, filed Oct 17, 2025. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Tiba Aynechi | Director |
| Percival Barretto Ko | Director |
| Simpson Camilla | Director |
| Ralph William Charlton Iii | Executive |
| Dina Chaya | Director |
| Samir Gharib | Executive |
| Michael Grey | Director, Executive |
| Jonas Hansson | Director |
| Richard King | Director, Executive |
| Bali Muralidhar | Director |
| Niall O'donnell | Director |
| Camilla Simpson | Director |
| Daniel Spiegelman | Director |
| Javier Szwarcberg | Director, Executive |
| Kirk Ways | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
611 Gateway Boulevard, Suite 740
South San Francisco, CA, 94080
South San Francisco, CA, 94080